Raymond Liang

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Restraining Lysosomal Activity Preserves Hematopoietic Stem Cell Quiescence and Potency

Raymond Liang, Tasleem Arif, Svetlana Kalmykova et al. · Cell stem cell · 2020 · 237 citations · Full text

Cell Division, Medicine, Genetics +11

Mitochondrial metabolism in hematopoietic stem cells requires functional <scp>FOXO</scp> 3

Pauline Rimmelé, Raymond Liang, Carolina L. Bigarella et al. · EMBO Reports · 2015 · 148 citations · Full text

Stem Cell Biology, Developmental Biology, Mitochondrial Biogenesis +8

Aging-like Phenotype and Defective Lineage Specification in SIRT1-Deleted Hematopoietic Stem and Progenitor Cells

Pauline Rimmelé, Carolina L. Bigarella, Raymond Liang et al. · Stem Cell Reports · 2014 · 146 citations · Full text

Young Sirt1-deleted Hscs, Genetics, Aging-like Phenotype +18

Consistent Patterns of Allelic Loss in Natural Killer Cell Lymphoma

Lisa L. P. Siu, Vivian Chan, John K. C. Chan et al. · American Journal Of Pathology · 2000 · 115 citations · Full text

Lymphoid Neoplasia, Autoimmune Disease, Immunology +7